BR112014006248A2 - compostos de triazolopiridina como inibidores de pde10a - Google Patents
compostos de triazolopiridina como inibidores de pde10aInfo
- Publication number
- BR112014006248A2 BR112014006248A2 BR112014006248A BR112014006248A BR112014006248A2 BR 112014006248 A2 BR112014006248 A2 BR 112014006248A2 BR 112014006248 A BR112014006248 A BR 112014006248A BR 112014006248 A BR112014006248 A BR 112014006248A BR 112014006248 A2 BR112014006248 A2 BR 112014006248A2
- Authority
- BR
- Brazil
- Prior art keywords
- triazolopyridine compounds
- pde10a inhibitors
- compounds
- pde10a
- triazolopyridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Obesity (AREA)
- Addiction (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11181752 | 2011-09-19 | ||
PCT/EP2012/068203 WO2013041472A1 (en) | 2011-09-19 | 2012-09-17 | Triazolopyridine compounds as pde10a inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112014006248A2 true BR112014006248A2 (pt) | 2017-04-11 |
Family
ID=46851999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014006248A BR112014006248A2 (pt) | 2011-09-19 | 2012-09-17 | compostos de triazolopiridina como inibidores de pde10a |
Country Status (18)
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2757883B1 (en) * | 2011-09-22 | 2021-01-13 | Merck Sharp & Dohme Corp. | Triazolopyridyl compounds as aldosterone synthase inhibitors |
US20140235667A1 (en) | 2011-09-22 | 2014-08-21 | Merck Sharp & Dohme Corp. | Imidazopyridyl compounds as aldosterone synthase inhibitors |
SG11201508924XA (en) * | 2013-04-30 | 2015-11-27 | Hoffmann La Roche | Pd-CATALYZED COUPLING OF PYRAZOLE AMIDES |
TWI652014B (zh) | 2013-09-13 | 2019-03-01 | 美商艾佛艾姆希公司 | 雜環取代之雙環唑殺蟲劑 |
JP6568855B2 (ja) | 2014-07-30 | 2019-08-28 | 持田製薬株式会社 | ピラゾール誘導体の製造方法 |
WO2016017719A1 (ja) * | 2014-07-30 | 2016-02-04 | 持田製薬株式会社 | ピラゾール誘導体の製造方法 |
WO2016144351A1 (en) | 2015-03-11 | 2016-09-15 | E. I. Du Pont De Nemours And Company | Heterocycle-substituted bicyclic azole pesticides |
BR112017019326B1 (pt) | 2015-03-12 | 2022-04-26 | Fmc Corporation | Composto, composição e método para controlar uma praga invertebrada |
KR20180057716A (ko) | 2015-10-08 | 2018-05-30 | 이 아이 듀폰 디 네모아 앤드 캄파니 | 헤테로사이클-치환된 비시클릭 아졸 살충제 |
BR112020003481B1 (pt) * | 2017-08-22 | 2023-12-05 | Bayer Aktiengesellschaft | Derivados de heterocicleno, seus usos, formulação agroquímica, e métodos para controlar pragas animais e para proteger sementes ou uma planta germinativa de pragas |
EP3978077B1 (en) | 2019-05-27 | 2023-11-29 | Nihon Nohyaku Co., Ltd. | Condensed heterocyclic compound having a bridgehead nitrogen atom or salt thereof, agricultural or horticultural insecticide comprising the compound, and method for using the insecticide |
AR119140A1 (es) | 2019-06-13 | 2021-11-24 | Pi Industries Ltd | Compuestos heterocíclicos fusionados y su uso como agentes de control de plagas |
CN110396157B (zh) * | 2019-08-07 | 2021-07-30 | 广州市建筑科学研究院有限公司 | 缓释型聚羧酸纳米减水剂及其制备方法和应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6355653B1 (en) * | 1999-09-06 | 2002-03-12 | Hoffmann-La Roche Inc. | Amino-triazolopyridine derivatives |
EP1651251A4 (en) | 2003-07-31 | 2008-06-18 | Bayer Pharmaceuticals Corp | METHOD FOR THE TREATMENT OF DIABETES AND RELATED DISEASES USING PDE 10A INHIBITORS |
NL2000397C2 (nl) * | 2006-01-05 | 2007-10-30 | Pfizer Prod Inc | Bicyclische heteroarylverbindingen als PDE10 inhibitoren. |
EP2348018A4 (en) * | 2008-09-25 | 2012-04-25 | Kyorin Seiyaku Kk | HETEROCYCLIC BIARYLIC DERIVATIVE AND PDE INHIBITOR COMPRISING THE SAME AS ACTIVE INGREDIENT |
WO2010059836A1 (en) * | 2008-11-20 | 2010-05-27 | Decode Genetics Ehf | Substituted aza-bridged bicyclics for cardiovascular and cns disease |
WO2010117926A1 (en) * | 2009-04-07 | 2010-10-14 | Schering Corporation | Substituted triazolopyridines and analogs thereof |
WO2011036127A1 (en) * | 2009-09-24 | 2011-03-31 | F. Hoffmann-La Roche Ag | Imidazopyridine or imidazopyrimidine derivatives as phosphodiesterase 10a inhibitors |
CN112019976A (zh) | 2009-11-24 | 2020-12-01 | 诺基亚技术有限公司 | 用于处理音频信号的设备和方法 |
TWI487705B (zh) * | 2009-12-17 | 2015-06-11 | Lundbeck & Co As H | 作為pde10a酵素抑制劑之雜芳香族芳基三唑衍生物 |
TWI485151B (zh) * | 2009-12-17 | 2015-05-21 | Lundbeck & Co As H | 作為pde10a酵素抑制劑之雜芳香族苯基咪唑衍生物 |
TW201200516A (en) * | 2009-12-17 | 2012-01-01 | Lundbeck & Co As H | Phenylimidazole derivatives comprising an ethynylene linker as PDE10A enzyme inhibitors |
-
2012
- 2012-09-17 WO PCT/EP2012/068203 patent/WO2013041472A1/en active Application Filing
- 2012-09-17 ES ES12759445.5T patent/ES2626801T3/es active Active
- 2012-09-17 KR KR1020147009588A patent/KR101584925B1/ko not_active IP Right Cessation
- 2012-09-17 CA CA2846758A patent/CA2846758C/en not_active Expired - Fee Related
- 2012-09-17 JP JP2014531187A patent/JP2014526533A/ja active Pending
- 2012-09-17 CN CN201280045398.XA patent/CN103827114B/zh not_active Expired - Fee Related
- 2012-09-17 UA UAA201404029A patent/UA108711C2/uk unknown
- 2012-09-17 PE PE2014000366A patent/PE20141553A1/es not_active Application Discontinuation
- 2012-09-17 AU AU2012311713A patent/AU2012311713A1/en not_active Abandoned
- 2012-09-17 SG SG11201400759RA patent/SG11201400759RA/en unknown
- 2012-09-17 BR BR112014006248A patent/BR112014006248A2/pt not_active IP Right Cessation
- 2012-09-17 MX MX2014003025A patent/MX2014003025A/es active IP Right Grant
- 2012-09-17 EA EA201490599A patent/EA201490599A1/ru unknown
- 2012-09-17 EP EP12759445.5A patent/EP2758396B1/en not_active Not-in-force
-
2014
- 2014-03-05 CO CO14047250A patent/CO6900144A2/es unknown
- 2014-03-06 IL IL231403A patent/IL231403A0/en unknown
- 2014-03-17 CL CL2014000641A patent/CL2014000641A1/es unknown
- 2014-03-18 US US14/218,275 patent/US8946427B2/en not_active Expired - Fee Related
- 2014-12-16 US US14/572,312 patent/US9227970B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CO6900144A2 (es) | 2014-03-20 |
US20140303141A1 (en) | 2014-10-09 |
WO2013041472A1 (en) | 2013-03-28 |
NZ621597A (en) | 2015-04-24 |
SG11201400759RA (en) | 2014-07-30 |
US20150099735A1 (en) | 2015-04-09 |
PE20141553A1 (es) | 2014-10-30 |
CN103827114A (zh) | 2014-05-28 |
EA201490599A1 (ru) | 2014-07-30 |
KR20140075716A (ko) | 2014-06-19 |
CL2014000641A1 (es) | 2014-11-14 |
CA2846758A1 (en) | 2013-03-28 |
KR101584925B1 (ko) | 2016-01-12 |
UA108711C2 (uk) | 2015-05-25 |
IL231403A0 (en) | 2014-04-30 |
US9227970B2 (en) | 2016-01-05 |
ES2626801T3 (es) | 2017-07-26 |
CA2846758C (en) | 2017-09-12 |
AU2012311713A1 (en) | 2014-03-13 |
EP2758396A1 (en) | 2014-07-30 |
JP2014526533A (ja) | 2014-10-06 |
US8946427B2 (en) | 2015-02-03 |
CN103827114B (zh) | 2016-08-24 |
EP2758396B1 (en) | 2017-03-29 |
MX2014003025A (es) | 2014-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014006248A2 (pt) | compostos de triazolopiridina como inibidores de pde10a | |
BR112012031343A2 (pt) | compostos de heteroarila contendo nitrogênio | |
BR112014026828A2 (pt) | compostos de triazolo como inibidores de pde10 | |
BR112012024199A2 (pt) | derivados de n-(imidazopirimidin-7-il)-heteroarilamida e seu uso como inibidores de pde10a | |
BR112013023876A2 (pt) | derivados de pirroltriazinona como inibidores de pi3k | |
BR112014003198A2 (pt) | compostos para o tratamento e profilaxia de doença por vírus sincicial respiratório | |
ECSP13012667A (es) | Compuestos de triazolopiridina | |
BR112015004984A2 (pt) | formulações aquosas estáveis de adalimumab | |
BR112014004522A2 (pt) | moduladores de pde10 | |
BR112015012919A2 (pt) | novos derivados de piridina | |
BR112015020795A2 (pt) | derivados de pirazol novos | |
BR112012017580A2 (pt) | derivados de heteroarila contendo nitrogênio | |
BR112015009600A2 (pt) | piridina-2-amidas úteis como agonistas cb2 | |
BR112012026338A2 (pt) | novos derivados de 3,3-dimetil tetrahidroquinolina | |
BR112015013124A2 (pt) | novos derivados de piridina | |
BR112015009603A2 (pt) | novos derivados de pirazina | |
BR112012006531A2 (pt) | derivados de imidazopirimidina ou imidazopiridina como inibidores da fosfodiesterase 10a. | |
BR112015012825A2 (pt) | piridopirazinas substituídas como inibidores de syk | |
BR112014028006A2 (pt) | heterociclos de pirrolidino | |
BR112014010047A2 (pt) | novos derivados de pirazina | |
BR112012015984A2 (pt) | composição para melhorar a função cerebral, e, polipeptídeo | |
RS53783B1 (en) | INHALATION MEDICINAL PRODUCTS INCLUDING TIOTROPIUM | |
BR112014016803A2 (pt) | amidas macrocíclicas como inibidoras de protease | |
CO6592109A2 (es) | Nueva forma cristalina de un derivado de ciclopropilbenzamida | |
BR112014012521A2 (pt) | novos derivados de pirrolidina como inibidores de catepsina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |